Apr 27Generate:Biomedicines and MD Anderson Enter Co-Development and Commercialization AgreementMulti-year collaboration will facilitate the co-development of optimized therapeutics that bind to challenging targets in ways...
Apr 13Sana Biotechnology Announces Preclinical Data Published in Nature CommunicationsHypoimmune-modified allogeneic CD19-directed CAR T cells can evade immune detection and kill tumor cells in a novel humanized allogeneic...